期刊文献+

食管胃结合部腺癌淋巴结转移规律对根治性放疗靶区勾画参考 被引量:11

The patterns of lymph node metastasis in adenocarcinoma of esophagogastric junction:a reference for target volume delineation in radical radiotherapy
原文传递
导出
摘要 目的:分析食管胃结合部腺癌的淋巴结转移分布特征。方法收集2006—2009年间393例食管胃结合部腺癌病理资料,分析不同 Siewert 分型、肿瘤浸润深度、肿瘤最大径等淋巴结转移特征和分布特点,探讨高危淋巴引流区。χ2检验组间差别。结果食管胃结合部腺癌腹腔淋巴结转移率为69.2%、转移度为31.31%,以贲门、胃小弯、胃左动脉、脾动脉、脾门、肠系膜根部及腹主动脉旁淋巴结转移发生率高。纵隔淋巴结转移率为16.4%、转移度为8.3%,以下段食管旁、食管裂孔及膈上区域淋巴结转移发生率高。 SiewertⅠ型较Ⅱ、Ⅲ型纵隔淋巴结转移率高(P=0.003),腹腔淋巴结转移度低(P=0.002)。 T3+T4期及肿瘤最大径≥6 cm 者淋巴结转移度在腹腔多个区域均高于对照组,纵隔淋巴结转移度在肿瘤最大径组间差别不明显。胃大弯、肝十二指肠韧带和膈下部位淋巴结转移度在不同组间均低于<10%。结论食管胃结合部腺癌放疗腹腔高危淋巴区域应包括贲门、胃小弯、胃左动脉、脾动脉、脾门旁、肠系膜根部及腹主动脉旁,纵隔高危淋巴引流区包括下段食管旁、食管裂孔及膈上区域,并依据不同 Siewert 分型及临床病理特征的淋巴结转移特点进行个体化靶区设计。 Objective To analyze the patterns and distribution of lymph node metastasis in patients with adenocarcinoma of the esophagogastric junction ( AEG). Methods The pathological data of 393 patients with AEG from 2006 to 2009 were analyzed. The patterns and distribution of lymph node metastasis were analyzed in patients with different Siewert subtypes, depths of tumor invasion, and maximum diameters of the tumor, and the high.risk lymphatic drainage areas were investigated. Between.group comparison was performed by χ2 test. Results The metastatic rate and ratio of abdominal lymph nodes in AEG were 69. 2%and 31. 31%, respectively. The incidence rates of lymph node metastasis in the cardia, lesser curvature, left gastric artery, splenic artery, splenic hilum, mesenteric root, and abdominal aorta were the highest. The metastatic rate and ratio of mediastinal lymph nodes were 16. 4% and 8. 3%, respectively. The incidence rates of lymph node metastasis in the lower paraesophageal, esophageal hiatus, and superior diaphragmatic areas were the highest. Compared with Siewert type II and type III AEG, Siewert type I AEG had a significantly higher mediastinal lymph node metastatic rate (P= 0. 003) and a significantly lower abdominal lymph node metastatic ratio (P= 0. 002).The metastatic ratios of lymph nodes in multiple abdominal regions were higher in patients with stage T3+T4 AEG and a maximum tumor diameter of ≥6 cm than in the control group, while the metastatic ratios of mediastinal lymph nodes in groups with different maximum tumor diameters were similar. The metastatic ratios of lymph nodes in the greater curvature, hepatoduodenal ligament, and inferior diaphragmatic areas were lower than 10% in all groups. Conclusions In radiotherapy for AEG, the abdominal high.risk lymphatic drainage areas involve the cardia, lesser curvature, left gastric artery, splenic artery, splenic hilum, mesenteric root, and abdominal aorta, while the mediastinal high.risk lymphatic drainage areas involve the lower paraesophageal, esophageal hiatus, and superior diaphragmatic areas. In addition, the personalized target volume design should be based on the patterns of lymph node metastasis with different Siewert subtypes and clinical pathological characteristics.
出处 《中华放射肿瘤学杂志》 CSCD 北大核心 2015年第4期367-371,共5页 Chinese Journal of Radiation Oncology
关键词 食管胃结合部肿瘤/ 放射疗法 靶区勾画 淋巴结转移 Esophagogastric junction neoplasm/ radiotherapy Target delineation Lymph node metastasis
  • 相关文献

参考文献18

  • 1Siewert J, HSlscher A, Becker K, et al. Cardia cancer: attempt at a therapeutically relevant classification [ J]. Chirurg, 1987,58 ( 1 ) : 25 -32.
  • 2Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005 [ J ].CA Cancer J Clin,2005,55 ( 1 ) : 10-30.
  • 3Piso P, Werner U, Lang H, et al. Proximal versus distal gastric car- cinoma-what are the differences? [J].Ann Surg Oncol, 2000, 7 (7) :520-525.
  • 4van Hagen P, Hulshof MC, van Lanschot JJ, et al. Preoperative chemoradiotherapy for esophageal or junctional cancer [ J]. N Engl J Med, 2012, 366 (22): 2074-2084. DOI: 10. 1056/NEJ- Moal 112088.
  • 5Stahl M,Walz MK, Stuschke M, et al. Phase IR comparison of pre- operative chemotherapy compared with chemoradiotherapy in pa- tients with locally advanced adenocarcinoma of the esophagogastric junction [ J ] .J Clin Oncol, 2009,27 (6) : 851-856. DOI : 10.1200/ JC O. 2008.17.0506.
  • 6Tepper J, Krasna M J, Niedzwiecki D, et al. Phase 111 trial of trimo- dality therapy with eisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781 [ J ].J Clin Oncol, 2008, 26 ( 7 ) : 1086-1092. DOI: 10. 1200/JCO. 2007.12.9593.
  • 7Pedrazzani C, de Manzoni G, Marrelli D, et al. Lymph node in- volvement in advanced gastroesophageal junction adenocarcinoma [ J] .J Thorac Cardiovasc Surg,2007,134(2) :378-385.
  • 8Mtinig SP, Baldus SE, Zirbes TK, et al. Topographical distribution of lymph node metastasis in adenocarcinoma of the gastroesophage- al junction [ J ]. Hepatogastroenterology, 2002,49 (44) : 419-422.
  • 9Feith M, Stein HJ,Siewert JR,et al. Adenocarcinoma of the esopha- gogastric junction:surgical therapy based on 1602 consecutive resec- ted patients [ J ].Surg Oncol Clin N Am, 2006,15 (4) : 751-764.
  • 10Meier I, Merkel S, Papadopoulos T, et al. Adenocarcinoma of the esophagogastric junction:the pattern of metastatic lymph node dis- semination as a rationale for elective lymphatic target volume defi- nition [ J] .Int J Radiat Oncol Biol Phys,2008,70(5) :1408-1417. DOI : 10.1016/j.ijrobp.2007.08.053.

二级参考文献17

共引文献122

同被引文献123

  • 1Cunningham D,Allum WH,Stenning SP,菅鑫妍.手术期间化学疗法与单独手术治疗可切除的胃食管癌疗效比较[J].中国处方药,2006,5(8):59-60. 被引量:434
  • 2李进东,王文光,许金良,高宗人,邵令方.胸段食管癌淋巴结转移特点的研究[J].中华医学杂志,2006,86(45):3197-3200. 被引量:33
  • 3王军,祝淑钗,韩春,张辛,肖爱勤,麻国新.1162例食管癌病理标本亚临床病灶范围的研究[J].中华放射肿瘤学杂志,2007,16(1):6-9. 被引量:25
  • 4陈志峰,侯浚,贺宇彤.食管胃交界腺癌——食管癌高发区面临的新课题[J].肿瘤防治研究,2007,34(11):883-885. 被引量:18
  • 5Keeney S, Bauer TL. Epidemiology of adeuocarcinoma of the esophagogastric junction [J].Surg Oncol Clin N Am, 2006, 15 (4) : 687-696.DOI : 10. 1016/j.soe.2006.07.014.
  • 6Kodera Y,Yamarnura Y, Shimizu Y, et al. Ad of the gastroesophageal junction in Japan: relevance of Siewert' s classification applied to 177 cases resected at a single institution [J].J Am Coll Surg, 1999, 189 (6) : 594-601. DOI: 10. 1016/ S1072-7515 ( 99 ) 00201-X.
  • 7Siewert JR, Feith M, Stein HJ. Biologic and clinical variations of adenocarcinoma at the esophago-gastric junction:relevance of a topographic-anatomic subclassifieatiou [ J ]. J Surg Oneol, 2005,90 (3) : 139-146.DOI : 10.1002/jso.20218.
  • 8Sasako M, Sano T, Yamamoto S, et al. Left thoracoabdominal approach versus abdominal-transhiatal approach for gastric cancer of the cardia or subcardia: a randomised controlled trial [ J ].Lancet Oncol, 2006, 7 ( 8 ) : 644-651. DOI: 10. 1016/S1470-2045 ( 06 ) 70766-5.
  • 9Macdonald JS, Smalley SR, Benedetti J, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction [ J] .N Engl J Med ,2001, 345 (10) : 725-730.DOI: 10.1056/NEJMoa010187.
  • 10Shapiro J, van Lanschot JJB, Hulshof MCCM, et al. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS) :long-term results of a randornised controlled trial [ J] .Lancet Oncol,2015,16(9) :1090- 1098.DOI : 10.1016/S1470-2045 (15) 00040-6.

引证文献11

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部